📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. (2020)

First Author: Alajati A

Attributed to: BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci131133

PubMed Identifier: 32250342

Publication URI: http://europepmc.org/abstract/MED/32250342

Type: Journal Article/Review

Volume: 130

Parent Publication: The Journal of clinical investigation

Issue: 5

ISSN: 0021-9738